Eligible patients ( with adequate stem-cell harvest ) were randomly assigned ( @:@ ) , using an automated telephone randomisation line , to either high-dose melphalan @ mg/m ( @ ) plus salvage ASCT or oral cyclophosphamide ( @mg/m ( @ ) per week for @ weeks ) .